Clot-buster boosts survival, decreases disability for deadly subset of stroke

New results from a multicentre study led by Johns Hopkins show that patients who got an experimental clot-busting treatment for a particularly lethal form of stroke were not only dramatically more likely to survive but also continued to shed lingering disabilities six months later. The findings, announced at the International Stroke Conference in San Diego on 19 February, are likely to build support for the use of tissue plasminogen activator (tPA) in patients with intracranial haemorrhage, a treatment-resistant form of stroke marked by brain bleeding...

Read the whole article on

More from